Centene Corp (CNC) stock
CNCNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 7/302% above fair value
$67.45−5.10 (-7.03%)
Close on Nov 18, 2026Market cap $33.39BP/E 23.1Yield –
Centene gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Centene's gross profit for the twelve months ending Sep 30, 2026 was $16.13B, up 4.4% year over year. For fiscal 2025 it was $14.21B, down 16.8% from the year before. Over ten years it grew -3.9% a year on average. The highest annual figure on record is $107.81B in fiscal 2020.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.21B | -16.8% |
| FY2024 | Dec 31, 2024 | $17.07B | -3.2% |
| FY2023 | Dec 31, 2023 | $17.64B | +4.2% |
| FY2022 | Dec 31, 2022 | $16.92B | +16.8% |
| FY2021 | Dec 31, 2021 | $14.49B | -86.6% |
| FY2020 | Dec 31, 2020 | $107.81B | +49.4% |
| FY2019 | Dec 31, 2019 | $72.17B | +25.0% |
| FY2018 | Dec 31, 2018 | $57.73B | +24.1% |
| FY2017 | Dec 31, 2017 | $46.54B | +20.1% |
| FY2016 | Dec 31, 2016 | $38.74B | +83.3% |
| FY2015 | Dec 31, 2015 | $21.14B | +38.3% |
| FY2014 | Dec 31, 2014 | $15.28B | +45.0% |
| FY2013 | Dec 31, 2013 | $10.54B | +31.3% |
| FY2012 | Dec 31, 2012 | $8.02B | +56.3% |
| FY2011 | Dec 31, 2011 | $5.13B | +17.1% |
| FY2010 | Dec 31, 2010 | $4.38B | +8.5% |
| FY2009 | Dec 31, 2009 | $4.04B | +22.2% |
| FY2008 | Dec 31, 2008 | $3.31B | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $3.30B | -1.3% |
| Q2 FY2026 | Jun 30, 2026 | $4.62B | +53.0% |
| Q1 FY2026 | Mar 31, 2026 | $5.65B | +6.8% |
| Q4 FY2025 | Dec 31, 2025 | $2.56B | -32.7% |
| Q3 FY2025 | Sep 30, 2025 | $3.35B | -16.5% |
| Q2 FY2025 | Jun 30, 2025 | $3.02B | -33.3% |
| Q1 FY2025 | Mar 31, 2025 | $5.29B | +11.7% |
| Q4 FY2024 | Dec 31, 2024 | $3.80B | +1.5% |
| Q3 FY2024 | Sep 30, 2024 | $4.01B | -13.5% |
| Q2 FY2024 | Jun 30, 2024 | $4.53B | -1.9% |
| Q1 FY2024 | Mar 31, 2024 | $4.74B | +1.9% |
| Q4 FY2023 | Dec 31, 2023 | $3.74B | -4.3% |
| Q3 FY2023 | Sep 30, 2023 | $4.63B | +14.5% |
| Q2 FY2023 | Jun 30, 2023 | $4.61B | +1.3% |
| Q1 FY2023 | Mar 31, 2023 | $4.65B | +5.5% |
| Q4 FY2022 | Dec 31, 2022 | $3.91B | -87.5% |
| Q3 FY2022 | Sep 30, 2022 | $4.04B | -87.0% |
| Q2 FY2022 | Jun 30, 2022 | $4.56B | -84.8% |
| Q1 FY2022 | Mar 31, 2022 | $4.41B | -84.8% |
| Q4 FY2021 | Dec 31, 2021 | $31.18B | +13.4% |
| Q3 FY2021 | Sep 30, 2021 | $31.05B | +10.0% |
| Q2 FY2021 | Jun 30, 2021 | $29.92B | +11.3% |
| Q1 FY2021 | Mar 31, 2021 | $28.94B | +14.8% |
| Q4 FY2020 | Dec 31, 2020 | $27.50B | +51.3% |
| Q3 FY2020 | Sep 30, 2020 | $28.23B | +53.8% |
| Q2 FY2020 | Jun 30, 2020 | $26.88B | +51.5% |
| Q1 FY2020 | Mar 31, 2020 | $25.20B | +40.8% |
| Q4 FY2019 | Dec 31, 2019 | $18.18B | +13.6% |
| Q3 FY2019 | Sep 30, 2019 | $18.36B | +18.0% |
| Q2 FY2019 | Jun 30, 2019 | $17.74B | +31.2% |
| Q1 FY2019 | Mar 31, 2019 | $17.90B | +41.5% |
| Q4 FY2018 | Dec 31, 2018 | $16.00B | +30.1% |
| Q3 FY2018 | Sep 30, 2018 | $15.56B | +35.8% |
| Q2 FY2018 | Jun 30, 2018 | $13.52B | +17.6% |
| Q1 FY2018 | Mar 31, 2018 | $12.65B | +12.1% |
| Q4 FY2017 | Dec 31, 2017 | $12.29B | +7.5% |
| Q3 FY2017 | Sep 30, 2017 | $11.46B | – |
| Q2 FY2017 | Jun 30, 2017 | $11.50B | – |
| Q1 FY2017 | Mar 31, 2017 | $11.28B | – |
| Q4 FY2016 | Dec 31, 2016 | $11.43B | – |
See a number that looks wrong?